文献速递老年慢病共病管理认知障碍与谵妄衰弱、肌少症与跌倒

老年胰岛素治疗2型糖尿病夜间低血糖被低估:HYPOAGE观察性研究

Nocturnal hypoglycemia is underdiagnosed in older people with insulin-treated type 2 diabetes: The HYPOAGE observational study.
PubMed 文献 · J Am Geriatr Soc · 2023-03-25

这项前瞻性多中心研究纳入155例75岁及以上胰岛素治疗的2型糖尿病患者,其中141例连续28天接受盲法动态血糖监测(CGM)。结果显示37.6%患者发生自我血糖监测(SMBG)证实的低血糖,65.2%患者出现夜间低血糖时间,夜间低血糖与认知障碍、心力衰竭和抑郁障碍相关。

要点

  • SMBG证实的低血糖(<70 mg/dL)发生于37.6%的老年胰岛素治疗T2D患者。
  • 65.2%患者出现夜间低血糖时间(0:00–6:00间连续≥15分钟血糖<54 mg/dL)。
  • 认知障碍和心力衰竭与夜间低血糖时间正相关,抑郁障碍呈负相关。

核心结论

  • 夜间低血糖在老年胰岛素治疗2型糖尿病患者中非常常见且很大程度上被漏诊,CGM是识别低血糖并调整糖尿病管理的有前景工具。

研究设计与样本

  • 前瞻性多中心观察性研究,纳入155例75岁及以上胰岛素治疗的2型糖尿病患者,要求每日至少2次SMBG;分析人群141例CGM有效时间>70%,连续28天佩戴FreeStyle Libre Pro®传感器进行盲法CGM。

主要发现

  • 141例分析患者平均年龄81.5±5.3岁,男性56.7%,基线HbA1c均值7.9%±1.0%;老年综合评估后102例(72.3%)为复杂,39例(27.7%)为健康。
  • 主要终点SMBG证实的低血糖(<70 mg/dL)发生于37.6%患者。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is a lack of real-life data regarding the frequency and predictive factors of hypoglycemia in older patients with type 2 diabetes (T2D). This study aimed to determine the frequency and predictors of hypoglycemia in older patients with insulin-treated T2D. METHODS: This prospective multicenter study included 155 insulin-treated T2D patients aged 75 years and older with ≥2 self-monitoring of blood glucose (SMBG) daily controls. Participants underwent a geriatric and diabetic assessment and received ambulatory blinded continuous glucose monitoring (CGM) for 28 consecutive days with FreeStyle Libre Pro® sensor. Study population (n = 141) has >70% CGM active time. Multivariable logistic regressions were used to identify factors associated with SMBG confirmed hypoglycemia (≥70 mg/dL) and with nocturnal level 2 time below range (glucose concentration <54 mg/dL during ≥15 consecutive min between 0.00 and 6.00 am). RESULTS: The mean age of the 141 analyzed patients was 81.5 ± 5.3 years and 56.7% were male. The mean baseline HbA1c was 7.9% ± 1.0%. After geriatric assessment, 102 participants (72.3%) were considered as complex and 39 (27.7%) as healthy. The primary endpoint (confirmed SMBG <70 mg/dL) occurred in 37.6% patients. In multivariable analysis, the risk of SMBG-confirmed hypoglycemia was positively associated with a longer duration of diabetes (OR (+1 year) =1.04, (1.00-1.08), p = 0.04) and glycemic variability assessed by CGM (CV %) (OR (+1%) = 1.12, [1.05-1.19], p = <0.001). Nighty-two patients (65.2%) experienced nocturnal time in hypoglycemia (i.e., <54 mg/dL during ≥15 consecutive min between midnight and 6 a.m.). In multivariable analyses, cognitive impairment (OR: 9.31 [2.59-33.4]), heart failure (OR: 4.81 [1;48-15.6]), and depressive disorder (OR: 0.19 [0.06-0.53]) were associated with nocturnal time in hypoglycemia. CONCLUSION: Nocturnal hypoglycemia is very common and largely underdiagnosed in older patients with insulin-treated T2D. CGM is a promising tool to better identify hypoglycemia and adapt diabetes management in this population.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Boureau AS, Guyomarch B, Gourdy P, et al. Nocturnal hypoglycemia is underdiagnosed in older people with insulin-treated type 2 diabetes: The HYPOAGE observational study. J Am Geriatr Soc. 2023. PMID: 36965179. doi:10.1111/jgs.18341

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。